Exploring a STAT6–STAT3 Anatomical Immune Divergence Model in Atopic Dermatitis: Implications for Dupilumab Responsiveness and Adult Scabies Sparing

Abstract

Get full access to this article

View all access options for this article.

References

1. Bangert

, Alkon

, Chennareddy

, et al. Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells. Nat Commun. 2024;15(1):2839; doi: 10.1038/s41467-024-46540-0

2. Perego

, Aromolo

, Barei

, et al. Effectiveness of dupilumab in atopic dermatitis on the head and neck: A single-center study on 553 patients. Int J Dermatol. 2024;63(8):e178–e179; doi: 10.1111/ijd.17278

3. See Tow

, Yew

. Malassezia specific IgE in head and neck dermatitis of eczema: A systematic review & meta-analysis. Exp Dermatol. 2024;33(6):e15108; doi: 10.1111/exd.15108

4. Wang

, Zheng

, Xu

, et al. Epidermal keratinocyte-specific STAT3 deficiency aggravated atopic dermatitis-like skin inflammation in mice through TSLP upregulation. Front Immunol. 2023;14:1273182; doi: 10.3389/fimmu.2023.1273182

5. Al-Dabbagh

, Younis

, Ismail

. The current available diagnostic tools and treatments of scabies and scabies variants: An updated narrative review. Medicine (Baltimore). 2023;102(21):e33805; doi: 10.1097/MD.0000000000033805